Effects of the somatostatin analog lanreotide on the circulating levels of chromogranin-A, prostate-specific antigen, and insulin-like growth factor-1 in advanced prostate cancer patients
2014 ◽
Vol 44
(12)
◽
pp. 1227-1232
◽
2002 ◽
Vol 89
(4)
◽
pp. 396-399
◽
2004 ◽
Vol 13
(1)
◽
pp. 163-165
◽